We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Weis Markets
WMK
$1.77B
| $1.39M | ﹤0.01% |
19,490
-1,573
| -7% | -$104K |
|
1377
Medifast
MED
$128M
| $1.39M | ﹤0.01% |
8,136
-3,640
| -31% | -$686K |
|
|
ILPT
1378
Industrial Logistics Properties Trust
ILPT
$611M
| $1.39M | ﹤0.01% |
61,225
+2,217
| +4% | +$50.6K |
|
1379
Encore Capital Group
ECPG
$2.15B
| $1.39M | ﹤0.01% |
22,108
+11,762
| +114% | +$767K |
|
|
MIME
1380
DELISTED
Mimecast Limited
MIME
| $1.38M | ﹤0.01% |
17,373
-3,327
| -16% | -$264K |
|
1381
LiveRamp
RAMP
$2.31B
| $1.38M | ﹤0.01% |
36,935
-41,793
| -53% | -$1.75M |
|
1382
NBT Bancorp
NBTB
$2.79B
| $1.37M | ﹤0.01% |
37,914
-29,992
| -44% | -$1.17M |
|
1383
BlueLinx
BXC
$705M
| $1.36M | ﹤0.01% |
18,976
+1,347
| +8% | +$110K |
|
|
SHYF
1384
DELISTED
The Shyft Group
SHYF
| $1.36M | ﹤0.01% |
37,769
+11,051
| +41% | +$470K |
|
1385
Cytokinetics
CYTK
$10.2B
| $1.36M | ﹤0.01% |
36,908
+543
| +1% | +$19.3K |
|
1386
Preferred Bank
PFBC
$1.28B
| $1.36M | ﹤0.01% |
18,332
-3,574
| -16% | -$277K |
|
|
SUM
1387
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.35M | ﹤0.01% |
44,323
+1,375
| +3% | +$45.8K |
|
1388
RLJ Lodging Trust
RLJ
$1.67B
| $1.35M | ﹤0.01% |
96,062
-17,785
| -16% | -$250K |
|
1389
First Commonwealth Financial
FCF
$2.19B
| $1.35M | ﹤0.01% |
89,157
+1,895
| +2% | +$30.8K |
|
1390
NRC Health Common Stock
NRC
$471M
| $1.35M | ﹤0.01% |
34,094
+21,894
| +179% | +$857K |
|
|
DOOR
1391
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.35M | ﹤0.01% |
15,142
+6,058
| +67% | +$599K |
|
|
ACH
1392
Accendra Health
ACH
$84.6M
| $1.34M | ﹤0.01% |
30,545
-11,520
| -27% | -$495K |
|
|
CSR
1393
Centerspace
CSR
$939M
| $1.34M | ﹤0.01% |
13,694
-4,634
| -25% | -$450K |
|
1394
Regenxbio
RGNX
$704M
| $1.34M | ﹤0.01% |
+40,491
| New | +$1.12M |
|
1395
Varonis Systems
VRNS
$5.26B
| $1.34M | ﹤0.01% |
28,245
+4,593
| +19% | +$188K |
|
|
ARGO
1396
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.34M | ﹤0.01% |
32,546
+28,405
| +686% | +$1.36M |
|
1397
PTC Therapeutics
PTCT
$6.01B
| $1.34M | ﹤0.01% |
35,975
+30,748
| +588% | +$1.18M |
|
1398
Innospec
IOSP
$2.31B
| $1.34M | ﹤0.01% |
14,487
-7,536
| -34% | -$714K |
|
1399
Protolabs
PRLB
$2.21B
| $1.34M | ﹤0.01% |
25,247
+2,279
| +10% | +$120K |
|
|
NVEE
1400
DELISTED
NV5 Global
NVEE
| $1.33M | ﹤0.01% |
40,072
-17,428
| -30% | -$512K |
|
Similar funds
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.